
    
      Objectives:

      The primary objective was to evaluate the dose-dependent efficacy of 2 dose-titration
      regimens of Eslicarbazepine Acetate (ESL) compared with placebo as therapy in patients with
      acute mania.

      The secondary objective was to evaluate the safety and tolerability of 2 dose-titration
      regimens of Eslicarbazepine Acetate in comparison to placebo.
    
  